Shandong Xinhua Pharmaceutical Company Limited provided group earnings guidance for the period from 1 January 2017 to 30 June 2017. The group is expected to record an increase in the net profit attributable to the shareholders for the period from 1 January 2017 to 30 June 2017, as compared to the corresponding period in 2016. The company estimated that net profits attributable to the equity holders of the company an increase of approximately 100%-150% as compared with the same period last year and Basic earnings per share to be approximately from RMB 0.20 to RMB 0.25.